Stock

Hims & Hers Health Inc.

000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol HIMS:xnys
Currency USD
united-states
New York Stock Exchange
Open Closed
15 minutes delayed
Data provided by Cboe Global Markets
This information is not currently available for this instrument. Refresh the page or try again later.
Instrument Card
Want to start investing?
Trade stocks with a broker trusted by over 1.5 million clients. Investing involves risk. You may lose some or all of your investment.

Chart

This information is not currently available for this instrument. Refresh the page or try again later.
Open account to access more charting and analysis tools

Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.

Quotes

  • Bid
  • Ask
  • Open
  • Previous close
  • Volume
  • Relative volume
  • High
  • Low
This information is not currently available for this instrument. Refresh the page or try again later.

Returns

Year to date (YTD) -9.49%
1 year 4.63%
3 years 154.68%
Data provided by FactSet Research Systems

Key stats

Price/earnings (LTM) 56.29
Dividend yield (LTM) -
EPS (LTM) 0.52
Volatility (30 days) 96.94%
Data provided by FactSet Research Systems

ESG risk

ESG risk score 22.47
Environmental score 0.39
Social score 15.36
Governance score 6.72
ESG risk category Medium
Negligible Low Med High Severe
0-10 10-20 20-30 30-40 40+

ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).

Download ESG risk methodology (PDF)
Data provided by Morningstar / Sustain Analytics

Financials

Q1 Q2 Q3 Q4
Income statement
Revenue XXXXXXX XXXXXXX XXXXXXX XXXXXXX
EBITDA XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Net income XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Balance sheet
Total assets XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Total debt XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Ratios
Price/sales XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Earnings per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Dividend per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Return on equity XXXXXXX XXXXXXX XXXXXXX XXXXXXX

About Hims & Hers Health Inc.

Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.

Sector Healthcare
Industry -
Market cap 7bn
Data provided by Morningstar / FactSet Research Systems

Hims & Hers Health, Inc. (HIMS) is a U.S.-based telehealth company that offers direct-to-consumer healthcare services and wellness products through a digital platform. Founded in 2017 and headquartered in San Francisco, California, the company connects users with licensed healthcare professionals for the treatment of common conditions in mental health, dermatology, sexual health, and primary care.

Through its website and mobile app, Hims & Hers enables users to complete virtual consultations—often asynchronously—and receive personalised treatment plans, with medications and wellness products delivered to their homes. The company operates under two consumer-facing brands: Hims (targeting men) and Hers (targeting women), both of which offer subscription-based access to prescription and over-the-counter products.

Hims & Hers also sells wellness and personal care items through e-commerce and retail partnerships. Its vertically integrated model combines pharmacy fulfilment, clinical operations, and proprietary technology to enhance accessibility, affordability, and user experience across routine and preventive care.

Hims & Hers Health is listed on the New York Stock Exchange (NYSE).

Data provided by Saxo
Saxo provides this content for general information only. It is not intended as personal advice, an offer, or a recommendation. Saxo does not guarantee accuracy or completeness and accepts no liability for losses. Consider obtaining independent advice before any investment decision.

Frequently asked questions

To buy Hims & Hers Health Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Hims & Hers Health Inc. by name or ticker, choose the number of shares, and place your order.

Learn about Saxo accounts.

The ticker symbol for Hims & Hers Health Inc. is HIMS:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.

Hims & Hers Health Inc. has its primary listing on New York Stock Exchange. You can trade Hims & Hers Health Inc. with a Saxo account, alongside thousands of other stocks worldwide.

Yes, Hims & Hers Health Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Hims & Hers Health Inc. as part of a broader investment portfolio.

Explore our SaxoInvestor platform.

Saxo Bank (Schweiz) AG
The Circle 38
CH-8058
Zürich-Flughafen
Switzerland

Contact Saxo

Switzerland
Switzerland

All trading carries risk. Losses can exceed deposits on margin products. You should consider whether you understand how our products work and whether you can afford to take the high risk of losing your money. To help you understand the risks involved we have put together a general Risk Warning series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. The KIDs can be accessed within the trading platform. Please note that the full prospectus can be obtained free of charge from Saxo Bank (Switzerland) Ltd. or the issuer.

This website can be accessed worldwide however the information on the website is related to Saxo Bank (Switzerland) Ltd. All clients will directly engage with Saxo Bank (Switzerland) Ltd. and all client agreements will be entered into with Saxo Bank (Switzerland) Ltd. and thus governed by Swiss Law. 

The content of this website represents marketing material and has not been notified or submitted to any supervisory authority.

If you contact Saxo Bank (Switzerland) Ltd. or visit this website, you acknowledge and agree that any data that you transmit to Saxo Bank (Switzerland) Ltd., either through this website, by telephone or by any other means of communication (e.g. e-mail), may be collected or recorded and transferred to other Saxo Bank Group companies or third parties in Switzerland or abroad and may be stored or otherwise processed by them or Saxo Bank (Switzerland) Ltd. You release Saxo Bank (Switzerland) Ltd. from its obligations under Swiss banking and securities dealer secrecies and, to the extent permitted by law, data protection laws as well as other laws and obligations to protect privacy. Saxo Bank (Switzerland) Ltd. has implemented appropriate technical and organizational measures to protect data from unauthorized processing and disclosure and applies appropriate safeguards to guarantee adequate protection of such data.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc.